The timeline for patients suffering with rare and orphan or specialty diseases to start therapy is critical, but the process can be daunting. FRM expertise is most necessary and valuable when payer policies, reimbursement, patient services, and care coordination are challenging or ambiguous for these therapies.
That’s where we can help. Our FRM reimbursement experts implement an efficient and compliant approach to speed up the time of treatment initiation. They serve as the liaisons of HCP and payer communications, alleviating administrative hurdles and prior authorization submissions and denials that HCP offices and patients face, and they partner with internal or external HUB providers and specialty pharmacies to expedite access.